Results 121 to 130 of about 122,296 (281)

Herpes Zoster vaccine revaccination data

open access: yes
Presentations June 2017 Day 1Agenda lists presentation as: Herpes Zoster vaccine revaccination dataPublication date from document properties.zoster-03-colindres ...

core  

Recurrent Herpes Zoster in Early Childhood

open access: yes, 2007
Herpes Zoster is produced by reactivation of latent Varicella Zoster Virus from the dorsal root ganglion of sensory nerves. It is common in older individuals and rarely described in the pediatric age group.
Nataraja Rathinam, S.   +5 more
core   +1 more source

Clinical and morphological characteristics of herpes zoster in south India

open access: yesIndian Journal of Dermatology, 2005
One hundred and seven cases (6 children and 101 adults) of herpes zoster were recruited over a period of two years. The frequency of herpes zoster amongst skin OPD cases was found to be 0.34 per cent. The male to female ratio was 1.74:1.
Dubey Anand   +2 more
doaj  

Herpes zoster

open access: yesNippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics, 2021
openaire   +3 more sources

Clinical Effectiveness of the Recombinant Zoster Vaccine for Preventing Herpes Zoster in Individuals With Kidney Transplants: A Retrospective Cohort Study

open access: yesTransplant Infectious Disease, EarlyView.
In this retrospective cohort of kidney transplant recipients, no herpes zoster cases occurred during 398 vaccinated person‐years, compared with 78 cases (16.4 per 1000 person‐years) among unvaccinated recipients. These findings support a protective association of the recombinant zoster vaccine (RZV) and reinforce current recommendations for ...
Kyungsup Kwon   +12 more
wiley   +1 more source

Herpes Zoster and Post-Herpetic Neuralgia—Diagnosis, Treatment, and Vaccination Strategies

open access: yesPathogens
Introduction: Herpes zoster is caused by the reactivation of latent varicella infection within the sensory ganglia, caused by the varicella-zoster virus (VZV).
Delwyn Zhi Jie Lim   +6 more
doaj   +1 more source

A Case Report of Herpes Zoster After Botulinum Toxin Injections [PDF]

open access: yes
Shadi Zari Department of Dermatology, College of Medicine, University of Jeddah, Jeddah, Saudi ArabiaCorrespondence: Shadi Zari, Department of Dermatology, College of Medicine, University of Jeddah, Saudi Arabia, Email Shadizarimd@gmail.comAbstract: This
Zari S
core  

Herpes Zoster Brachial Plexopathy: Direct Steroid Injection

open access: yes, 2017
Herpes zoster (shingles) is a viral disease, characterized by painful skin eruptions and neuropathic sensory symptoms. Motor involvement and brachial plexus involvement in herpes zoster are rare conditions.
Askin, Suna, Yilmaz, Cem, Araz, Coskun
core   +1 more source

Efficacy and Field Safety of the Second‐Generation, Highly Selective JAK1 Inhibitor Atinvicitinib for the Treatment of Canine Atopic Dermatitis: A Multicentre, Blinded, Randomised, Placebo‐Controlled Clinical Trial in Client‐Owned Dogs

open access: yesVeterinary Dermatology, EarlyView.
Background: Janus kinase (JAK) inhibitors alleviate pruritus and clinical signs of canine atopic dermatitis (cAD). Objective: To confirm the optimal dosing regimen of atinvicitinib, a second‐generation highly selective inhibitor of JAK1 in dogs. Conclusions and Clinical Relevance: Once‐daily atinvicitinib was safe, well‐tolerated and effective at ...
Faris Jirjis   +6 more
wiley   +1 more source

Herpes zoster as a vaccine-preventable risk factor increases the risk of dementia: A nested case-control study in Chinese population

open access: yesHuman Vaccines & Immunotherapeutics
Herpes zoster, a vaccine-preventable disease caused by the reactivation of varicella-zoster virus, has been linked to an increased risk of dementia in high-income countries. However, evidence from populations with low vaccination coverage remains limited.
Binshan Jiang   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy